Reducing Sugar-sweetened Beverage Consumption Among Young Adults

January 18, 2019 updated by: University of California, Davis
This study aims to test sugar-sweetened beverage (SSB) health labeling elements in an online experiment to determine which elements are the most salient among young adults.

Study Overview

Study Type

Interventional

Enrollment (Actual)

2971

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Davis, California, United States, 95616
        • University of California, Davis

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion criteria:

  • ≥18 years of age
  • current/recent (<1 year of graduation) undergraduate student at 3 specific universities
  • English-speaking
  • consumes at least 2 SSBs per week

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Loss-frame, text-only, no attribution
Label participants will see is loss-frame, text-only, and with no attribution
loss frame label
text-only label
label with no attribution
Experimental: Gain-frame, text-only, no attribution
Label participants will see is gain-frame, text-only, and with no attribution
text-only label
label with no attribution
gain frame label
Experimental: Loss-frame, icon, no attribution
Label participants will see is loss-frame, icon, and with no attribution
loss frame label
label with no attribution
label with icon and text
Experimental: Grain-frame, icon, no attribution
Label participants will see is gain-frame, with an icon, and with no attribution
label with no attribution
gain frame label
label with icon and text
Experimental: Loss-frame, icon, attribution
Label participants will see is loss-frame, icon, and with attribution
loss frame label
label with icon and text
label with attribution
Experimental: Gain-frame, icon, attribution
Label participants will see is grain-frame, icon, and with attribution
gain frame label
label with icon and text
label with attribution
Experimental: Loss-frame, text-only, attribution
Label participants will see is loss-frame, text-only, and with attribution
loss frame label
text-only label
label with attribution
Experimental: Gain-frame, text-only, attribution
Label participants will see is gain-frame, text-only, and with attribution
text-only label
gain frame label
label with attribution
Placebo Comparator: No label
Participant will not see a label
No label

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
SSB Intention
Time Frame: Up to 20 minutes
Intention to consume SSBs measured by hypothetical selection of a beverage from images of beverage options.
Up to 20 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
SSB Intention (2)
Time Frame: Up to 20 minutes
Measured by survey items assessing intention to consume SSBs on a scale from 1 (not at all likely) to 7 (extremely likely).
Up to 20 minutes
SSB attitudes
Time Frame: Up to 20 minutes
Measured by survey items assessing perceived healthfulness of SSBs on a scale from 1 (extremely unhealthy) to 7 (extremely healthy).
Up to 20 minutes
SSB knowledge
Time Frame: Up to 20 minutes
Measured by survey items assessing knowledge of number of calories (estimate provided by participant) and sugar (estimated by participant, in teaspoons) contained in SSBs.
Up to 20 minutes
SSB norms
Time Frame: Up to 20 minutes
Measured by survey item assessing how often participants perceive their peers to consume SSBs (1 = multiple times a day, 2 = daily, 3 = weekly, 4 = less than once a week, and 5 = never) and item on perception that people who are important to the participant would want them to limit SSB intake, on a scale from 1 (not at all) to 5 (completely) .
Up to 20 minutes

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
SSB self-efficacy
Time Frame: Up to 20 minutes
Measured by survey item assessing how confident participant feels in reducing SSB consumption, on a scale from 1 (not at all) to 5 (completely).
Up to 20 minutes
Social interaction
Time Frame: Up to 20 minutes
Measured by survey item assessing likelihood participant will encourage others to reduce SSB consumption, on a scale from 1 (not at all) to 5 (completely).
Up to 20 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jennifer Falbe, ScD, MPH, University of California, Davis

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 18, 2018

Primary Completion (Actual)

November 17, 2018

Study Completion (Actual)

November 17, 2018

Study Registration Dates

First Submitted

September 10, 2018

First Submitted That Met QC Criteria

September 12, 2018

First Posted (Actual)

September 14, 2018

Study Record Updates

Last Update Posted (Actual)

January 23, 2019

Last Update Submitted That Met QC Criteria

January 18, 2019

Last Verified

January 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • 1124060
  • 1K01DK113068-01A1 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Health Knowledge, Attitudes, Practice

Clinical Trials on loss-frame

Subscribe